河北医科大学学报

• 论著 • 上一篇    下一篇

4项血清肿瘤标志物联合检测在肺癌中的应用价值分析

  

  1. 1.新疆维吾尔自治区人民医院北院检验科,新疆 乌鲁木齐 830054;2.新疆维吾尔自治区人民医院临检中心,新疆 乌鲁木齐 830001
  • 出版日期:2018-07-25 发布日期:2018-07-04
  • 作者简介:单新洁(1981-),女,新疆乌鲁木齐人,新疆维吾尔自治区人民医院主管检验师,医学学士,从事临床检验学研究。
  • 基金资助:
    国家重点基础研究发展计划(2012CB722414)

The value of combined detection of 4 serum tumor markers in lung cancer#br#

  1. 1.Department of North Hospital Clinical Laboratory, Xinjiang Uygur Autonomous Region
    People′s Hospital, Urumqi 830054, China; 2.The Center of Clinical Laboratory, Xinjiang
    Uygur Autonomous Region People′s Hospital, Urumqi 830001, China
  • Online:2018-07-25 Published:2018-07-04

摘要: [摘要]〓
〖HTH〗目的〖HTSS〗〖KG*2〗评价血清胃泌素释放肽前体(progastrinreleasing peptide,ProGRP)、鳞状上皮细胞癌抗原(squamous cell carcinoma antigen,SCCAg)、细胞角蛋白19片段抗原(cytokerantin 19 fragment,Cyfra211)及癌胚抗原(carcinoembryonic antigen,CEA) 4项肿瘤标志物联合诊断肺癌的价值。
〖HTH〗方法〖HTSS〗〖KG*2〗随机抽取肺癌患者71例、肺部良性疾病106例和健康体检者214例,采集3组受试者的肘正中静脉血样,采用酶联免疫吸附测定法检测4项肿瘤标志物水平。比较3组受试者4项肿瘤标志物的水平、阳性率和阳性指标数,并比较4项肿瘤标志物单独和联合诊断肺癌的诊断效能(灵敏度、特异度、准确度、阳性预测值和阴性预测值)。
〖HTH〗结果〖HTSS〗〖KG*2〗肺癌组血清ProGRP、SCCAg、Cyfra211和CEA水平、阳性率和阳性指标数均显著高于健康对照组和良性疾病组(P<005)。ROC曲线显示,4项肿瘤标志物单独诊断肺癌时,ProGRP的AUC最大(AUC=0.898),CEA(AUC=0.873)和 Cyfra211(AUC=0.813)次之,SCCAg最低(AUC=0.798);4项标志物联合诊断后AUC得到了显著提高(AUC=0.975);约登指数得出的最佳截点为〖JP2〗ProGRP>47.5 ng/L、SCCAg>2.12 μg/L、Cyfra211>3.41 μg/L和CEA>5.98 μg/L。〖JP〗4项肿瘤标志物联合诊断的准确度、灵敏度、特异度、阳性预测值和阴性预测值均显著高于单独诊断。
〖HTH〗结论〖HTSS〗〖KG*2〗应用ProGRP、SCCAg、Cyfra211及CEA联合诊断肺癌具有较高的诊断效能。

关键词: 肺肿瘤, 肿瘤标记, 生物学, 诊断

Abstract: [Abstract]〓Objective〖HTSS〗〓To evaluate the value of progastrinreleasing peptide(ProGRP), Squamous cell carcinoma antigen(SCCAg), Cytokeratin 19 fragment antigen(Cyfra211) and carcinoembryonic antigen(CEA) of 4 tumor markers in combined diagnosis of lung cancer.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓 The 71 cases of lung cancer, 106 cases of benign lung diseases and 214 cases of healthy subjects were randomly selected. The median blood samples from the elbow of 3 groups were collected and the levels of 4 tumor markers were detected by enzymelinked immunosorbent assay. The level of 4 tumor markers, the positive rate and the number of positive indicators in the 3 groups were compared. The diagnostic efficiency(sensitivity, specificity, accuracy, positive predictive value and negative predictive value) of 4 tumor markers alone and combined in the diagnosis of lung cancer were compared.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓The levels of serum ProGRP, SCCAg, Cyfra211 and CEA, positive rate and positive index in lung cancer group were significantly higher than those in healthy control group and benign disease group(P<005). The ROC curve showed that when 4 tumor markers were diagnosed separately for lung cancer, AUC of ProGRP was the largest(AUC=0.898), CEA(AUC=0.873) and Cyfra211(AUC=0.813) were less, and SCCAg(AUC=0.798) were the lowest. The AUC of the 4 markers was increased significantly after combined diagnosis(AUC=0.975). The best cutoff point Youden index is derived ProGRP>47.5 ng/L, SCCAg>2.12 g/L, Cyfra211>3.41 g/L and CEA>5.98 g/L. The accuracy, sensitivity, specificity, positive predictive value and negative predictive value of 4 tumor markers combined diagnosis were significantly higher than those of separate diagnosis. 
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓The combined diagnosis of lung cancer with ProGRP, SCCAg, Cyfra211 and CEA has high diagnostic efficiency.

Key words: lung neoplasms, tumor markers, biological, diagnosis